Visuospatial Navigation: An Emerging Biomarker for Mild Cognitive Impairment and Alzheimer's

Current neuroimaging and biomarker research is strongly focused on identifying individuals at high risk of developing dementia. In contrast, cognitive markers for early stage of Alzheimer’s disease are virtually non-existent, as diagnostics tool and outcomes measures remain centered on episodic memory deficits despite their low sensitivity and specificity for identifying at-risk individuals.